Answers are grounded in this paper and cite their sources.
Preclinical investigation reveals anti-obesity effects of Hirsutella sinensis polysaccharides via Parabacteroides goldsteinii, indicating novel prebiotic and probiotic therapies for metabolic disease.
HSM polysaccharides and the gut bacterium P. goldsteinii represent novel prebiotics and probiotics that may be used to treat obesity and type 2 diabetes.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: